Top Story

Merck Initiates Phase III Study of Breast Cancer Vaccine
PharmaAsia, 7/1/2009
Merck has announced the initiation of its global Phase III clinical study of the therapeutic cancer vaccine Stimuvax (BLP25 liposome vaccine, L-BLP25) in patients with advanced, inoperable breast cancer.

The STRIDEa ...

[Full story | More stories]

Recent stories

• USP Signs Agreements with Chinese Drug Control Authorities
• GSK and Shenzhen Neptunus to Develop Vaccines in China
• Health Leaders Convene in Korea to Save Women's Lives
• Astrazeneca and Merck Collaborate to Investigate Anticancer Regimen
• Sanofi Pasteur Lands US$190 Million Order from the US Government

Latest News

VBI Researchers Develop Method for Breast Cancer Biomarker Discovery
PharmaAsia, 7/3/2009
Biocon and Mylan Collaborate to Enter Global Generic Biologics Market
PharmaAsia, 7/3/2009
GVK Biosciences Announces Agreement with University of Tokyo on GPCR Database
PharmaAsia, 7/2/2009
Gentronix and Apredica to Create Predictive-Toxicology Service
PharmaAsia, 7/2/2009
Astrazeneca: Pozen Submits NDA For Pn400
PharmaAsia, 7/1/2009
Reproducible Cell Migration Screening Assay
PharmaAsia, 6/30/2009
Discovery of Cell Water Gate May Lead to New Cancer Drugs
PharmaAsia, 6/30/2009

Science

VBI Researchers Develop Method for Breast Cancer Biomarker Discovery
PharmaAsia, 7/3/2009 Understanding Asthma for New Treatment Potential
PharmaAsia, 6/29/2009 Cytopia Cancer Program Reaches Milestone
PharmaAsia, 6/15/2009 Richter-Helm BioLogics: Breakthrough in Purification of Antibody Fragments
PharmaAsia, 6/8/2009 Sigma-Aldrich Introduces Kinases for High-Throughput Screening
PharmaAsia, 5/28/2009

Business

Biocon and Mylan Collaborate to Enter Global Generic Biologics Market
PharmaAsia, 7/3/2009 GVK Biosciences Announces Agreement with University of Tokyo on GPCR Database
PharmaAsia, 7/2/2009 Gentronix and Apredica to Create Predictive-Toxicology Service
PharmaAsia, 7/2/2009 Astrazeneca: Pozen Submits NDA For Pn400
PharmaAsia, 7/1/2009 China Pharma Holdings: SFDA Approval for Clinical Trials
PharmaAsia, 6/29/2009

New Products

Reproducible Cell Migration Screening Assay
PharmaAsia, 6/30/2009 Applied Biosystems Introduces Real-time PCR Solution
PharmaAsia, 6/19/2009 Concentration of Protein from a Single Drop
PharmaAsia, 6/16/2009 Esco Launches Perchloric Acid Laboratory Fume Hood
PharmaAsia, 6/15/2009 Qiagen Launches Product to Replace Invasive Procedures
PharmaAsia, 6/9/2009

[More]

Cover Stories

API Manufacturing: Complying with International GMP Regulations
PharmaAsia, 6/1/2009 Cell-Based Assays: Advancing Discovery
PharmaAsia, 5/1/2009 Pharmacogenomics: Bringing Hope
PharmaAsia, 3/1/2009 Establishing the Standards in Biomarkers Research
PharmaAsia, 1/1/2009 Robust Standards in Proteomic Research
PharmaAsia, 11/1/2008

[More]

Current Issue

Discovery of Cell Water Gate May Lead to New Cancer Drugs